Melanotan II Peptide Screening Form Template

Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) that stimulates melanogenesis, resulting in increased skin pigmentation. It is prescribed off-label through compounding pharmacies for photoprotection and tanning support. Due to its activity on melanocortin receptors, careful dermatologic and cardiovascular screening is essential before prescribing. This form documents tanning and pigmentation symptoms while screening for dermatologic and cardiovascular contraindications.

4 sections
17 fields
HIPAA-ready
3 citations

Free Template

Melanotan II Peptide Screening Form

Preview Form Automate This Form
No account required to use template
Customize with your practice branding
Reviewed against HIPAA & DEA guidelines

Form Preview

This is how the form appears to patients. Customize with your practice name and branding.

Your Practice Name

Melanotan II Peptide Screening Form

Preview
1

General Patient Information

Please provide your personal information.

First Name

Jane

Last Name

Smith

Date of Birth

Can you confirm you are 18 years or older?

Height

e.g. 5'8"

Weight

e.g. 170 lbs

2

Medical History

Please answer all questions as accurately as possible. Your provider will review this information.

Are you actively taking any medications? If so, please list them.

List all current medications, dosages, and frequencies

Do you have any medication allergies? If so, please list them.

List all known drug allergies and reactions

Are you currently being treated or have you been treated for any medical conditions? If so, please list them.

List all current and past medical conditions

Have you had any past surgeries? If so, please list them.

List all surgeries and approximate dates

What is/was your sex assigned at birth?

Male

Emergency contact name and phone number

Name — (555) 000-0000

Mailing address

123 Main St, City, State, ZIP

Any other questions or concerns?

Optional — share anything else you'd like your provider to know

3

Symptoms

Select all symptoms that currently apply to you.

Which of the following symptoms are you experiencing?
4

Medical Conditions

Select all conditions that currently apply to you.

Do any of the following apply to you?

Preview only. Your live form will include your branding and e-signature capture.

Submit

Compliance & Regulatory Notes

Review these notes before deploying this form in your practice.

Melanotan II is not FDA-approved and is prescribed off-label. Documented informed consent is required. See FSMB: https://www.fsmb.org

A history of melanoma or skin cancer is an absolute contraindication. All patients should have a baseline dermatologic evaluation and mole mapping recommended before initiating therapy.

Melanotan II can cause nausea, facial flushing, and erections as common side effects. Cardiovascular patients require additional evaluation.

Melanotan II must be dispensed by a licensed compounding pharmacy. See FDA: https://www.fda.gov/drugs/human-drug-compounding

Want This Form Automated?

Karpa Health turns static intake forms into a fully automated clinical workflow. Branded, HIPAA-compliant, and connected to compounding pharmacies.

  • Branded intake on your website
  • AI contraindication screening
  • One-click prescribing to pharmacies
  • Automated refill management
  • E-signatures and HIPAA audit trail
  • 50-state provider network included
Book a Demo

Free 30-minute walkthrough

Sources & References

  1. FDA Human Drug Compounding Guidance
  2. FSMB Off-Label Prescribing Guidelines
  3. American Academy of Dermatology Melanoma Guidelines

Frequently Asked Questions

Is Melanotan II safe for patients with moles?

Patients with atypical moles, a history of changing moles, or personal/family history of melanoma should be evaluated by a dermatologist before considering Melanotan II. Baseline dermatologic photography is often recommended.

What side effects should patients expect from Melanotan II?

Common side effects include nausea, facial flushing, fatigue, spontaneous erections (in males), and increased libido. These often diminish with continued use. Patients should be counseled on all expected effects before starting.